The Information Commissioner’s Office (ICO) has initiated an investigation into the use of Oxevision, a controversial camera-based monitoring system deployed in the bedrooms of mental health patients across the National Health Service (NHS). This system, employed by approximately 40% of NHS mental health trusts, has drawn sharp criticism from patients, advocacy groups, and bereaved families. The primary concern centers around data protection laws and the ethical implications of continuous surveillance in a setting meant for healing and recovery.
Oxevision uses infrared cameras and sensors to monitor patients 24 hours a day, recording live, unblurred video footage. While the company behind the system, LIO Health (previously known as Oxehealth), claims that the technology enhances patient safety and reduces the workload of NHS staff, many users describe it as invasive and unsettling. Patients have likened the experience to "spying" and "creepiness," while some have expressed heightened anxiety and paranoia due to the constant presence of cameras.
The controversy surrounding Oxevision has intensified following the Lampard inquiry, which is examining the deaths of numerous mental health patients in Essex. Among those affected was Sophie Alderman, a 27-year-old woman with a history of severe mental illness and self-harm. Her mother, Tammy Smith, testified during the inquiry that the Oxevision system likely exacerbated Sophie’s condition, increasing her sense of paranoia and distress. Despite the system’s purported ability to detect emergencies, it reportedly failed to ensure her safety, leading to her tragic suicide in August 2022.
Legal representatives for the campaign group Stop Oxevision have raised concerns regarding the legality of the data collection practices associated with Oxevision. They argue that the system lacks a clear lawful basis for collecting, processing, and retaining patient data. Rachel Harger, a partner at Bindmans Law, emphasized that the sanctity of a patient’s bedroom in a hospital should prioritize privacy and care, with any data collection requiring explicit, informed consent that can be freely withdrawn.
The ICO’s investigation comes amid growing scrutiny of the technology’s implementation within the NHS. The Parliamentary and Health Service Ombudsman recently ruled in favor of a patient, Miss B, who was subjected to Oxevision surveillance without her consent. The ombudsman found that the Essex Partnership University NHS Foundation Trust had violated several standards, including failing to inform the patient adequately about the technology and not respecting her request to disable the camera. The trust was ordered to pay compensation to Miss B for the psychological distress caused by the surveillance.
Critics of Oxevision highlight additional concerns beyond data privacy. They argue that the use of such intrusive technology in mental health wards may exacerbate emotional distress among patients, particularly those already dealing with complex mental health conditions. Selen Cavcav from the charity Inquest noted that the reliance on surveillance systems might detract from the quality of care, emphasizing the need for alternatives that prioritize patient dignity and autonomy.
The integration of Oxevision into NHS facilities has also sparked discussions about the role of private technology firms in healthcare. There are concerns about the potential for commercial interests to overshadow patient welfare, particularly when sensitive data is collected and processed. These worries are compounded by the involvement of large tech companies like Palantir, whose tax strategies have come under scrutiny for exploiting loopholes to minimize their contributions to the UK economy.
As the ICO continues its investigation, the focus remains on ensuring that the rights and well-being of mental health patients are protected. The outcomes of this probe could influence future policies regarding the use of surveillance technology in healthcare settings, potentially reshaping how patient data is handled and monitored moving forward.
4 reports
The Guardian (UK)IndependentCenterFactual 95Objective 9014 days agoThe UK's Information Commissioner's Office (ICO) has initiated an investigation into the use of Oxevision, a camera-based monitoring system deployed in the bedrooms of mental health patients across 40% of NHS mental health trusts. Concerns have been raised regarding data protection issues, with some patients describing the technology as 'creepy' and a form of 'spying.' A bereaved mother attributed her daughter's increased paranoia to the system prior to her suicide. Oxehealth, the company behind Oxevision, claims the system enhances patient safety and reduces the workload of NHS staff. Legal代表
Bias read (Center): The article presents both perspectives—concerns raised by patients and advocates, alongside the company's defense of the technology. It does not exhibit overtly biased language, one-sided sourcing, or omission of key viewpoints. The framing remains balanced.
Why these scores (Factual 95 · Objective 90): High factual accuracy with direct quotes from Bindmans lawyer Rachel Harger, aligning with primary source material. The article presents both sides of the issue (patient concerns vs. company claims). Slight bias in describing the system as 'creepy' and 'spying' may affect objectivity.
openDemocracyIndependentLeft6 days agoThis article investigates how Palantir, a technology firm, significantly reduced its UK tax liability despite generating substantial revenue from public contracts. The report highlights concerns over corporate tax avoidance, particularly at a time when there is increased scrutiny of government contracts such as the Federated Data Platform. The piece includes reactions from politicians like Liberal Democrat MP Martin Wrigley and Green Party deputy leader Mothin Ali, who criticize Palantir's minimal tax contributions. The article also covers other topics, including labor exploitation in Kenya related to TikTok content moderation, China's technological advancements, and political developments in the UK.
Bias read (Left): The article frames the issue of corporate tax avoidance as a significant problem, criticizing Palantir's actions and quoting progressive politicians who express concern over the company's minimal tax contributions. This suggests a critical stance toward corporate behavior and a focus on holding big
openDemocracyIndependentLeft7 days ago Exclusive: How Palantir harvested millions in UK tax breaksAn investigative report by openDemocracy reveals that Palantir, a controversial technology firm, is receiving substantial tax benefits in the UK, allowing it to pay minimal corporate tax despite high profits. The report highlights that Palantir secured at least £670 million in UK public contracts, making the UK its second-largest market after the US. However, its UK tax payments accounted for less than 5% of its global cash tax spend. According to US filings, Palantir's UK subsidiary paid less than £820,000 in cash tax in 2025, significantly below tax payments in other countries like France and Germany. The company's low tax exposure is attributed to strategic arrangements limiting UK profit recognition and a UK tax code provision offering incentives for employee stock compensation. Experts note these strategies are legally valid but raise concerns about corporate tax avoidance.
Bias read (Left): The article frames Palantir's tax practices as exploitative and raises ethical concerns about corporate influence on public institutions like the NHS. It emphasizes the disparity between the company's profitability and its minimal tax contributions, suggesting systemic issues in how large firms use稅
Novara MediaIndependentCenter10 days agoA senior lawyer representing campaigners has warned that NHS trusts using Oxevision, an AI-powered bedroom surveillance technology, face 'clear legal risk' due to potential violations of patient rights and lack of proper consent. The Parliamentary and Health Service Ombudsman recently ruled that Essex Partnership University NHS Foundation Trust failed to obtain consent from a patient, Miss B, who was monitored using Oxevision during her stay. The ombudsman found that the trust did not adequately inform Miss B about the technology, did not turn off the camera when requested, and kept insufficient records of its use. This led to the trust paying compensation to Miss B for the distress caused. Campaigners argue that the use of Oxevision raises significant concerns about patient privacy, consent, and the psychological impact on individuals, particularly in mental health settings. While the technology's developer claims it improves patient safety and reduces staff workload, critics highlight the ethical and legal challenges associated with continuous surveillance.
Bias read (Center): The article presents both perspectives—critics highlighting legal and ethical concerns regarding patient privacy and consent, and the developers defending the technology as beneficial for patient safety. It does not exhibit strong bias toward either side, providing balanced quotes and facts without顯
★
Keep the news honest.
ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €5/month.
Become a Supporter
United Kingdom
